BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu B, Li D, Xu T, Luo M, He Z, Li Y. Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system. Sci Rep 2021;11:3690. [PMID: 33574396 DOI: 10.1038/s41598-021-83099-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liao X, Liu Z, Song H. Thyroid dysfunction related to vascular endothelial growth factor receptor tyrosine kinase inhibitors: A real-world study based on FAERS. J Clin Pharm Ther 2021. [PMID: 34169545 DOI: 10.1111/jcpt.13472] [Reference Citation Analysis]
2 Inoue M, Matsumoto K, Tanaka M, Yoshida Y, Satake R, Goto F, Shimada K, Mukai R, Hasegawa S, Suzuki T, Ikesue H, Liao J, Hashida T, Nakamura M. Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database. Sci Rep 2021;11:11324. [PMID: 34059747 DOI: 10.1038/s41598-021-90848-6] [Reference Citation Analysis]
3 Huang WC, Wang MT, Lai TS, Lee KH, Shao SC, Chen CH, Su CH, Chen YT, Sung JM, Chen YC. Nephrotoxins and acute kidney injury - The consensus of the Taiwan acute kidney injury Task Force. J Formos Med Assoc 2022:S0929-6646(21)00572-6. [PMID: 34998658 DOI: 10.1016/j.jfma.2021.12.007] [Reference Citation Analysis]
4 Han N, Oh JM, Kim IW. Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems. Ther Clin Risk Manag 2021;17:877-87. [PMID: 34456568 DOI: 10.2147/TCRM.S321789] [Reference Citation Analysis]